He continued to serve as CEO and board member till 2000, two years after INNX had become the first biotech company to list on EASDAQ in 1998 (a new European stock exchange for growth companies).
He remained in charge as CEO and board member until 2000, two years after INNX became the first biotech firm to list on EASDAQ in 1998 (a new European stock exchange for growing companies).